Pfizer and BioNTech to offer COVID vaccine to volunteers who got placebo

By: |
January 2, 2021 11:25 AM

Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.

pfizer biontech vaccine to placebo participantsThe U.S. Food and Drug Administration and a panel of its outside advisers have expressed concerns over Pfizer's "unblinding" plan.

Pfizer Inc and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine by March 1, 2021, while staying within the study.

The trial’s Vaccine Transition Option allows all participants aged 16 or older the choice to discover whether they were given the placebo, “and for participants who learn they received the placebo, to have the option to receive the investigational vaccine while staying in the study,” the companies said on their website https://www.covidvaccinestudy.com/participants for trial participants.

The U.S. Food and Drug Administration and a panel of its outside advisers have expressed concerns over Pfizer’s “unblinding” plan, saying it could make it harder to continue collecting data on safety and effectiveness needed to win full FDA approval of the vaccine.

Trial participants who received the placebo will have two doses of the investigational vaccine reserved for them within the study, the companies said on the website.

“The study doctor will follow the latest guidance from the U.S. Centers for Disease Control and Prevention and their local health authorities to offer the Vaccine Transition Option to participants in a prioritized manner,” the companies said.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Want Pfizer vaccines? Modi govt must make purchase commitment: Pharma giant on India supply
2COVID-19 pandemic may take four to five years to end; uncertainities to remain: Singapore Minister
3India records 9,102 fresh COVID-19 cases, 117 fatalities in a day